A detailed history of Central Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Central Trust CO holds 16,585 shares of AZN stock, worth $1.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,585
Previous 18,185 8.8%
Holding current value
$1.15 Million
Previous $1.42 Million 23.31%
% of portfolio
0.03%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

SELL
$63.2 - $79.58 $101,120 - $127,328
-1,600 Reduced 8.8%
16,585 $1.09 Million
Q3 2024

Oct 22, 2024

BUY
$76.67 - $87.62 $735,878 - $840,976
9,598 Added 111.77%
18,185 $1.42 Million
Q2 2024

Aug 05, 2024

SELL
$66.81 - $80.83 $16,702 - $20,207
-250 Reduced 2.83%
8,587 $669,000
Q1 2024

Apr 24, 2024

SELL
$61.03 - $69.57 $15,135 - $17,253
-248 Reduced 2.73%
8,837 $598,000
Q4 2023

Jan 24, 2024

SELL
$61.89 - $69.28 $30,387 - $34,016
-491 Reduced 5.13%
9,085 $611,000
Q3 2023

Oct 26, 2023

BUY
$64.85 - $71.7 $13,229 - $14,626
204 Added 2.18%
9,576 $648,000
Q2 2023

Jul 26, 2023

BUY
$69.91 - $75.81 $67,812 - $73,535
970 Added 11.54%
9,372 $670,000
Q1 2023

Apr 19, 2023

BUY
$63.15 - $71.6 $14,777 - $16,754
234 Added 2.86%
8,402 $583,000
Q4 2022

Jan 26, 2023

SELL
$54.21 - $70.44 $161,979 - $210,474
-2,988 Reduced 26.78%
8,168 $0
Q3 2022

Nov 17, 2022

BUY
$53.02 - $135.75 $41,461 - $106,156
782 Added 7.54%
11,156 $611,000
Q2 2022

Aug 09, 2022

SELL
$59.26 - $71.14 $19,852 - $23,831
-335 Reduced 3.13%
10,374 $686,000
Q1 2022

May 03, 2022

SELL
$55.72 - $67.12 $85,753 - $103,297
-1,539 Reduced 12.57%
10,709 $710,000
Q4 2021

Feb 08, 2022

SELL
$54.02 - $63.83 $5,510 - $6,510
-102 Reduced 0.83%
12,248 $713,000
Q3 2021

Oct 19, 2021

SELL
$55.56 - $60.79 $2,833 - $3,100
-51 Reduced 0.41%
12,350 $741,000
Q2 2021

Jul 23, 2021

BUY
$48.42 - $60.18 $486,233 - $604,327
10,042 Added 425.69%
12,401 $742,000
Q1 2021

Apr 23, 2021

SELL
$47.16 - $54.44 $419,205 - $483,917
-8,889 Reduced 79.03%
2,359 $117,000
Q4 2020

Jan 29, 2021

SELL
$48.52 - $58.02 $16,254 - $19,436
-335 Reduced 2.89%
11,248 $562,000
Q3 2020

Oct 22, 2020

BUY
$53.07 - $61.1 $222,628 - $256,314
4,195 Added 56.78%
11,583 $634,000
Q2 2020

Jul 14, 2020

BUY
$43.1 - $55.31 $234,119 - $300,443
5,432 Added 277.71%
7,388 $390,000
Q4 2019

Jan 21, 2020

BUY
$42.46 - $50.46 $806 - $958
19 Added 0.98%
1,956 $97,000
Q3 2019

Oct 28, 2019

BUY
$40.12 - $45.47 $32,095 - $36,376
800 Added 70.36%
1,937 $86,000
Q2 2019

Jul 12, 2019

SELL
$37.28 - $41.68 $29,824 - $33,344
-800 Reduced 41.3%
1,137 $0
Q2 2018

Jul 09, 2018

SELL
$34.55 - $37.05 $11,436 - $12,263
-331 Reduced 14.59%
1,937 $0
Q1 2018

Apr 04, 2018

SELL
$32.97 - $36.63 $17,243 - $19,157
-523 Reduced 18.74%
2,268 $0
Q4 2017

Jan 23, 2018

BUY
$32.09 - $34.78 $12,322 - $13,355
384 Added 15.95%
2,791 $0
Q3 2017

Oct 17, 2017

BUY
$28.96 - $34.0 $69,706 - $81,838
2,407
2,407 $0

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $214B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.